We are seeking individuals with a current diagnosis of Pre-Diabetes or Type 2 Diabetes Mellitus diagnosed within the last 2 years. The purpose of the study is to understand the effects of applying personalized lifestyle recommendations on markers associated with Type 2 Diabetes based on each participant’s unique biological makeup. The intervention will be delivered through, Shae, a precision health app. Individuals who participate will receive free ongoing access to the Shae platform with a value of AU$270/yr
research-t2d
- Home
- research-t2d
research-t2d
The Shae Type 2 Diabetes Research Trial
Participant landing page and initial expression of interest
Trial Overview
Trial Registration:
Aus NZ Clinical Trials Registry Number
ACTRN12622000668707
Type 2 Diabetes is considered a lifestyle disease that, if not appropriately managed/treated can lead to significant disability and negatively impact the lives of those with the condition. It has been established that lifestyle factors (nutrition, exercise, sleep, stress and social wellbeing) make a big difference to the development, progression and treatment of the disease, however, due to the individual differences between people,not everyone gains the same benefit from the same recommendations
This study will examine the effect of providing personalized lifestyle guidance to individuals, based on their individual differences, on markers associated with Type 2 Diabetes.
The study will include 100-120 participants and will run for 6 months. Participants will be provided with access to personalized lifestyle suggestions through the Shae app, and will receive resources and workshops to support the development of knowledge, awareness and behaviour change based on the personalized lifestyle suggestions.
Some individuals will be asked to live their normal lifestyles for a period of time before entering the trial to allow a comparison of standard care with the personalized lifestyle approach.
The first wave of active intervention is set to being late August/Early September, 2022 The second wave of active intervention will being 6-6.5 months after the first wave, i.e. Feb/March 2023
Are you or someone you know eligible?
Please follow the following questions to understand your initial eligibility for the trial.
ARE YOU A HEALTH PROFESSIONAL? Please ensure the participant is eligible based on STEPS 1-3
If you find that you are not eligible for this particular study, please see how you can gain access to personalized support for your health at the bottom of this page: ‘Further Support Outside This Study’
I have read the inclusion criteria below and I/my clients are eligible for the trial
1
STEP - PRIMARY CRITERIA
-
Have you been diagnosed by your medical practitioner with Type 2 Diabetes in the last 24 months?
If Yes, please proceed to STEP 2
If NO, please continue
-
Have you been diagnosed with and currently have Pre-Diabetes? (as determined by your medical practitioner following blood tests)
If Yes, please proceed to STEP 2
If Unsure but believe you may be eligible, please see Step 1A
If NO but think you may still be eligible, please got to Step 4
- Are you aged between 35 and 65 years of age?
- Do you have a smart mobile phone capable of browsing the internet and downloading apps?
- Have internet access.
- An Australian or New Zealand Resident.
- Fluent in English.
- Willing to be randomly allocated to a group that has an immediate start or a group that has a waiting time of up to 6 months from the start of the study.
If you answered YES to all of the above questions, please go to STEP 3
If you answered NO to any of the above questions but want further clarity as to whether you can participate, please confirm eligibility through STEP 3, then see the details to email us
If you answered NO to any of the above questions, please see ‘Further Support Outside This Study’ below.
2
STEP - You cannot be part of this particular study if you are/have been:
You must answer ‘NO’ to the following criteria
- Currently experiencing heart failure, or have a previous diagnosis of heart failure
- Pregnant, breastfeeding or planning pregnancy in the next 12-18 weeks
- Currently taking warfarin or another anti-coagulant
- Any other contraindications identified by your medical practitionerIf you answered ‘NO’ to all criteria in STEP 2, you are likely to be eligible for the trial. Please go to STEP 3
- Any other contraindications identified by your medical practitioner
- Currently requiring insulin for management of Type 2 Diabetes
If you answered ‘NO’ to all criteria in STEP 2, you are likely to be eligible for the trial. Please go toSTEP 3
If you or your clients/patients are eligible, please use this form to register your interest in the trial, and our team will be in touch with you.
I don't believe I am eligible, but would like further support. Please read on to see how we can provide:
Further Support Outside This Study
If you are determined ineligible for this particular study, but are wishing to have personalized support for your condition(s), please complete the following form to be connected with a suitable health professional that may be able to assist you in a private health care setting, or if you were recommended by a Precision Health Practitioner, please contact them for your best pathway forward.